This inventor holds 1 USPTO granted patent. Top assignee: Immunometabolism Development Co., LLC. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Philipe Gobeil: Innovator in Antibody Development
Introduction
Philipe Gobeil is a notable inventor based in Toronto, Canada. He has made significant contributions to the field of immunology, particularly in the development of antibodies. His work is characterized by a focus on innovative solutions that address critical health challenges.
Latest Patents
Philipe Gobeil holds a patent for "ANTI-MCT1 ANTIBODIES AND USES THEREOF." This patent represents his commitment to advancing medical science through the development of targeted therapies.
Career Highlights
Gobeil is currently associated with Immunometabolism Development Co., LLC, where he continues to push the boundaries of research and innovation. His career is marked by a dedication to improving health outcomes through scientific discovery.
Collaborations
Philipe collaborates with esteemed colleagues such as Sergey Seregin and Kimberly P Shigenaka. These partnerships enhance the research environment and foster innovative ideas in the field.
Conclusion
Philipe Gobeil is a prominent figure in the realm of antibody development, with a focus on creating impactful medical solutions. His work exemplifies the spirit of innovation in the scientific community.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile